Serious adverse events (at 56 weeks) · patients with Crohn's disease (active disease population with clinical response at baseline)
It is very uncertain whether infliximab changes serious adverse events (at 56 weeks) compared with adalimumab (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with Crohn's disease (mixed disease activity population with clinical response at baseline)
It is very uncertain whether infliximab changes withdrawal due to adverse events (at 32‐54 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events (at 54 weeks) · patients with Crohn's disease (mixed disease activity population with clinical response at baseline)
It is very uncertain whether infliximab changes serious adverse events (at 54 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether surgical thrombectomy changes patency at 30 days compared with pulse spray technique (very low certainty).
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes patency at 30 days compared with pulse spray technique (very low certainty).
1 finding from 1 review
Failure · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes failure compared with pulse spray technique (very low certainty).
1 finding from 1 review
Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes technical success compared with pulse spray technique (very low certainty).
1 finding from 1 review
Failure · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether surgical thrombectomy changes failure compared with pulse spray technique (very low certainty).
1 finding from 1 review
Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes major adverse events compared with pulse spray technique (very low certainty).
1 finding from 1 review
Minor adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes minor adverse events compared with pulse spray technique (very low certainty).
1 finding from 1 review
Death · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes death compared with pulse spray technique (very low certainty).
1 finding from 1 review
Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether continuous Infusion changes patency at 30 days compared with pulse spray technique (very low certainty).
1 finding from 1 review
Failure · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether continuous Infusion changes technical success compared with pulse spray technique (very low certainty).
1 finding from 1 review
Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found